• Develop framework for opportunity and portfolio evaluation as part of annual 5-yr roadmap planning • Synthesize data across Market Intelligence and Product Strategy, Operations, Project Management, Tech, R&D, Finance and Data analytics teams • Evaluate strategic options across the molecular diagnostics portfolio, including product development, evidence generation, and infrastructure investments • Support portfolio prioritization decisions by assessing tradeoffs across risk, return, timing, and strategic fit • Update program and portfolio value for review at quarterly intervals and recommend project prioritization • Build and own enterprise financial models (DCF, NPV, IRR, scenario analysis) to assess long-term value creation of initiatives • Quantify the financial impact of potential R&D, operations, and product decisions • Partner with Finance and FP&A to align long-range plans with strategic priorities • Partner with Investor Relations to understand investor valuation perspectives of portfolio and financial decisions • Develop concise, executive-ready presentations and materials for senior leadership and board discussions • Translate financial information into clear recommendations • Support annual strategic planning and long-range planning processes